Pretreatment lymphopenia is an easily detectable predictive and prognostic marker in patients with metastatic esophagus squamous cell carcinoma receiving first‐line chemotherapy

To explore the influence of pretreatment lymphopenia on the toxicity and efficacy of first‐line chemotherapy in patients with metastatic esophagus squamous cell carcinoma (ESCC). In total, 215 patients were included in this retrospective study. Correlations between pretreatment lymphopenia (lymphocy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kou, Furong, Lu, Zhihao, Li, Jian, Zhang, Xiaotian, Lu, Ming, Zhou, Jun, Wang, Xicheng, Gong, Jifang, Gao, Jing, Li, Jie, Li, Yan, Shen, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864807/
https://www.ncbi.nlm.nih.gov/pubmed/26814381
http://dx.doi.org/10.1002/cam4.638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864807/
https://www.ncbi.nlm.nih.gov/pubmed/26814381
http://dx.doi.org/10.1002/cam4.638

Ejemplares similares